STOCK TITAN

ATEC Form 144 shows 15,625 shares proposed sale; prior 152,688 shares sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Alphatec Holdings, Inc. filed a Form 144 reporting a proposed sale of 15,625 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $245,625. The sale is listed for execution approximately on 08/13/2025 on NASDAQ, against a total of 147,983,775 shares outstanding.

The securities were acquired on 02/24/2023 as 7,011 Performance Stock Units and 8,614 Restricted Stock Units, which together equal the 15,625 shares proposed for sale. The filing also discloses prior sales in the past three months totaling 152,688 shares for gross proceeds of approximately $1,971,447.50, several of which are identified as 10b5-1 plan transactions. The filer attests to no undisclosed material adverse information in connection with the notice.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Proposed sale is small relative to outstanding shares; recent 3‑month insider sales total ~152.7k shares ($1.97M), a modest amount.

The proposed 15,625‑share sale represents approximately 0.0106% of the company's outstanding shares (15,625 of 147,983,775), indicating negligible direct dilution or market impact from this single transaction. Recent cumulative insider sales of 152,688 shares equal roughly 0.103% of outstanding shares and generated about $1.97M in gross proceeds. These numbers are small relative to the total share base, so from a pure ownership and dilution perspective the activity is immaterial.

TL;DR: Sales include multiple 10b5-1 plan executions and the filer certifies no undisclosed material information, indicating procedural compliance.

The filing documents that several prior sales were executed under Rule 10b5-1 arrangements for the named individual, which typically reflect preplanned dispositions rather than opportunistic trading. The filer also includes the standard representation that no material nonpublic information is known. These elements suggest the transactions follow established insider‑trading compliance processes; they do not, by themselves, signal material corporate governance or disclosure concerns based on the information provided.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Alphatec Hldgs Inc

NASDAQ:ATEC

ATEC Rankings

ATEC Latest News

ATEC Latest SEC Filings

ATEC Stock Data

2.37B
117.02M
20.83%
69.1%
8.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CARLSBAD